PTC Therapeutics (PTCT) director receives new stock and option awards

robot
Abstract generation in progress

Jessica Caroline Chutter, a director at PTC Therapeutics (PTCT), was granted new equity awards on March 24, 2026, including stock options for 3,475 and 2,896 shares at an exercise price of $64.54 per share. She also received 4,000 restricted stock units vesting over three years and 3,333 restricted stock units with vesting dates in June 2026 and January 2027. These transactions are compensation-related grants, not open-market purchases or sales.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin